[1] |
Levi M, Ten Cate H. Disseminated intravascular coagulation [J]. N Engl J Med, 1999, 341(8): 586-592.
|
[2] |
Erez O, Novack L, Beerweisel R, et al. DIC Score in Pregnant Women-A Population Based Modification of the International Society on Thrombosis and Hemostasis Score [J]. PLoS One, 2014, 9(4): e93240.
|
[3] |
Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management [J]. Am J Obstet Gynecol, 2016, 213(4): 452-463.
|
[4] |
Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta [J]. Semin Thromb Hemost, 2003, 29(2):175-184.
|
[5] |
Lockwood CJ, Krikun G, Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium [J]. Ann N Y Acad Sci, 2001, 943: 77-88.
|
[6] |
Schatz F, Krikun G, Caze R, et al. Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis [J]. Steroids, 2003, 68(10-13): 849-860.
|
[7] |
Hellgren M. Hemostasis during normal pregnancy and puerperium [J]. Semin Thromb Hemost, 2003, 29(2): 125-130.
|
[8] |
高旖鑫,梁国强,蒋艳敏,等. 不同孕期妇女FⅩ和FⅫ活性变化 [J]. 微循环学杂志,2013, 23(2): 57-58.
|
[9] |
Brenner B. Haemostatic changes in pregnancy [J]. Thromb Res, 2004, 114(5-6): 409-414.
|
[10] |
James AH, Rhee E, Thames B, et al. Characterization of antithrombin levels in pregnancy [J]. Thromb Res, 2014, 134(3): 648-651.
|
[11] |
Erez O, Romero R, Hoppensteadt D, el al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA [J]. J Matern Fetal Neonatal Med, 2008, 21(12):855-869.
|
[12] |
Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management [J]. Blood Rev, 2009, 23(4):167-176.
|
[13] |
Rattray DD, O′Connell CM, Baskett TF. Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009) [J]. J Obstet Gynaecol Can, 2012, 34(4): 341-347.
|
[14] |
Levi M, Van der Poll T. Inflammation and coagulation [J]. Crit Care Med, 2010, 38(2 Suppl): S26-S34.
|
[15] |
Pacheco LD, Saade G, Hankins GD, et al. Amniotic fluid embolism: diagnosis and management [J]. Am J Obstet Gynecol, 2016, 215(2):B16-B24.
|
[16] |
Cunningham FG, Nelson DB. Disseminated Intravascular Coagulation Syndromes in Obstetrics [J]. Obstet Gynecol, 2015, 126(5): 999-1011.
|
[17] |
Hall DR. Abruptio placentae and disseminated intravascular coagulopathy [J]. Semin Perinatol, 2009, 33(3):189-195.
|
[18] |
Dam PV. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia [J]. Obstet Gynecol, 1989, 73(1): 97-102.
|
[19] |
Levi M, Meijers JC. DIC: which laboratory tests are most useful [J]. Blood Rev, 2011, 25(1): 33-37.
|
[20] |
中华医学会血液学分会血栓与止血学组. 弥散性血管内凝血诊断与治疗中国专家共识(2012年版) [J].中华血液学杂志,2012, 33(11): 978-979.
|
[21] |
Jr TF, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation [J]. Thromb Haemost, 2001, 86(5): 1327-1330.
|
[22] |
Gando S, Iba T, Eguchi Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria [J]. Crit Care Med, 2006, 34(3):625-631.
|
[23] |
中华医学会血液学分会血栓与止血学组. 弥散性血管内凝血诊断与治疗中国专家共识(2017年版) [J].中华血液学杂志,2017, 38(5): 361-363.
|
[24] |
Wang L, Matsunaga S, Mikami Y, et al. Pre-delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption [J]. J Obstet Gynaecol Res, 2016, 42(7):796-802.
|
[25] |
Charbit B, Mandelbrot L, Samain E, et al.The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage [J]. J Thromb Haemost, 2007, 5(2):266-273.
|